The global continuous glucose monitoring device market size is expected to reach USD 10.4 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 12.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.
These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward continuous glucose monitoring (CGM) systems market growth.
For More Details Please Visit @:
Further key findings from the study suggest:
Grand View Research has segmented the global continuous glucose monitoring device market on the basis of component, end use, and region:
CGM Devices Component Outlook (Revenue, USD Million, 2016 – 2027)
CGM Devices End-use Outlook (Revenue, USD Million, 2016 – 2027)
CGM Devices Regional Outlook (Revenue, USD Million, 2016 – 2027)